rs148789453

Variant summary

Our verdict is Pathogenic. The variant received 7 ACMG points: 7P and 0B. PP4_ModeratePM2_SupportingPM3PP3_Moderate

This summary comes from the ClinGen Evidence Repository: The NM_000203.5: c.713T>A variant in IDUA is a missense variant predicted to cause substitution of Leu by Gln at amino acid 238 (p.Leu238Gln). This variant has been detected in at least 18 individuals with MPS I, the majority of whom had phenotypes consistent with a clinical diagnosis of Hurler-Scheie (PMID:32188113, 31839529, 34984346, 26260077, 28125077, and others). All of those individuals were compound heterozygous for the variant and another variant that has been classified as pathogenic or likely pathogenic by the ClinGen Lysosomal Diseases; it is unknown if these variants were confirmed in trans. For example, in compound heterozygous patients, the second variant is p.Gln70Ter (1 patient, 0.5 points, PMID:31194252), p.Trp402Ter (2 patients, 2 x 0.5 points, PMID:31194252), c.386-2A>G (1 patient 0.5 points, PMID:31194252), p.Glu182Lys (1 patient, 0.5 points, PMID:31194252), Int3-2a>g (1 patient, 0.5 points, PMID:31839529) and 63del (one patient, 0.5 points, PMID:31839529)Total 4 points (PM3_VeryStrong). One of these individuals was an adult male with clinical features consistent with MPS I including coarse facial features, joint stiffness, heart murmur, mitral and aortic stenosis, retinal degeneration and optic disc edema, and ventriculomegaly, elevated urine keratan sulfate and dermatan sulfate, undetectable serum IDUA activity (PMID:34984346) (PP4_Moderate). The highest population minor allele frequency in gnomAD v4.1.0 is 0.00004 (3/74,858 alleles) in the African/African American population, which is lower than the ClinGen Lysosomal Diseases VCEP’s threshold for PM2_Supporting (<0.00025), meeting this criterion (PM2_Supporting). Another missense variant c.713T>C p.Leu238Pro in the same codon has been reported in the ClinVar database in association with MPS I (ClinVar Variation ID 1517837). However, this variant has not yet been evaluated by the ClinGen Lysosomal Diseases VCEP (PM5 not met). Expression of the variant in CHO cells showed 5.88% wild type IDUA activity (PMID:15300847). However, this result does not meet the requirements for use by the ClinGen Lysosomal Diseases VCEP to apply PS3_Supporting criterion because the activity level was above the threshold of <2% established for this assay. The computational predictor REVEL gives a score of 0.904, which is above the threshold of 0.773, evidence that correlates with impact to IDUA function at the moderate level based on the specifications of the ClinGen Lysosomal Diseases VCEP (PMID:36413997) (PP3_Moderate). There is a ClinVar entry for this variant (Variation ID: 265418). In summary, this variant meets the criteria to be classified as Pathogenic for MPS I based on the IDUA-specific ACMG/AMP criteria applied, as specified by the ClinGen Lysosomal Diseases Variant Curation Expert Panel (Specifications Version 1.0.0): PM3_Very Strong, PP3_Moderate, PP4_Moderate, PM2_Supporting.(Classification approved by the ClinGen Lysosomal Diseases Variant Curation Expert Panel on December 6, 2024) LINK:https://erepo.genome.network/evrepo/ui/classification/CA2802065/MONDO:0001586/091

Frequency

Genomes: 𝑓 0.000020 ( 0 hom., cov: 34)
Exomes 𝑓: 0.0000041 ( 0 hom. )

Consequence

IDUA
NM_000203.5 missense

Scores

9
8
1

Clinical Significance

Pathogenic reviewed by expert panel P:8

Conservation

PhyloP100: 6.04

Publications

14 publications found
Variant links:
Genes affected
IDUA (HGNC:5391): (alpha-L-iduronidase) This gene encodes an enzyme that hydrolyzes the terminal alpha-L-iduronic acid residues of two glycosaminoglycans, dermatan sulfate and heparan sulfate. This hydrolysis is required for the lysosomal degradation of these glycosaminoglycans. Mutations in this gene that result in enzymatic deficiency lead to the autosomal recessive disease mucopolysaccharidosis type I (MPS I). [provided by RefSeq, Jul 2008]
IDUA Gene-Disease associations (from GenCC):
  • mucopolysaccharidosis type 1
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women’s Health, ClinGen
  • Scheie syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae), G2P
  • Hurler syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Genomics England PanelApp
  • Hurler-Scheie syndrome
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 7 ACMG points.

PM2
For more information check the summary or visit ClinGen Evidence Repository.
PM3
For more information check the summary or visit ClinGen Evidence Repository.
PP3
For more information check the summary or visit ClinGen Evidence Repository.
PP4
For more information check the summary or visit ClinGen Evidence Repository.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000203.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IDUA
NM_000203.5
MANE Select
c.713T>Ap.Leu238Gln
missense
Exon 6 of 14NP_000194.2P35475-1
IDUA
NM_001363576.1
c.317T>Ap.Leu106Gln
missense
Exon 5 of 13NP_001350505.1
IDUA
NR_110313.1
n.801T>A
non_coding_transcript_exon
Exon 6 of 14

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
IDUA
ENST00000514224.2
TSL:2 MANE Select
c.713T>Ap.Leu238Gln
missense
Exon 6 of 14ENSP00000425081.2P35475-1
IDUA
ENST00000247933.9
TSL:1
c.713T>Ap.Leu238Gln
missense
Exon 6 of 14ENSP00000247933.4P35475-1
IDUA
ENST00000962389.1
c.788T>Ap.Leu263Gln
missense
Exon 7 of 15ENSP00000632448.1

Frequencies

GnomAD3 genomes
AF:
0.0000197
AC:
3
AN:
152184
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0000482
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000218
AC:
5
AN:
229094
AF XY:
0.0000239
show subpopulations
Gnomad AFR exome
AF:
0.000144
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000291
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000413
AC:
6
AN:
1452456
Hom.:
0
Cov.:
34
AF XY:
0.00000554
AC XY:
4
AN XY:
722324
show subpopulations
African (AFR)
AF:
0.0000299
AC:
1
AN:
33404
American (AMR)
AF:
0.00
AC:
0
AN:
43840
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25940
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39408
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85424
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48948
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5758
European-Non Finnish (NFE)
AF:
0.00000451
AC:
5
AN:
1109692
Other (OTH)
AF:
0.00
AC:
0
AN:
60042
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000197
AC:
3
AN:
152184
Hom.:
0
Cov.:
34
AF XY:
0.0000269
AC XY:
2
AN XY:
74340
show subpopulations
African (AFR)
AF:
0.0000482
AC:
2
AN:
41454
American (AMR)
AF:
0.00
AC:
0
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4826
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10624
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68016
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.442
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.0000207
Hom.:
0
Bravo
AF:
0.0000113
ESP6500AA
AF:
0.000228
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00000831
AC:
1

ClinVar

ClinVar submissions
Significance:Pathogenic
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
4
-
-
Mucopolysaccharidosis type 1 (4)
2
-
-
not provided (2)
1
-
-
Hurler syndrome (1)
1
-
-
IDUA-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.89
BayesDel_addAF
Pathogenic
0.39
D
BayesDel_noAF
Pathogenic
0.52
CADD
Pathogenic
26
DANN
Uncertain
0.99
DEOGEN2
Pathogenic
0.97
D
Eigen
Uncertain
0.65
Eigen_PC
Uncertain
0.56
FATHMM_MKL
Uncertain
0.87
D
LIST_S2
Benign
0.78
T
M_CAP
Pathogenic
0.75
D
MetaRNN
Pathogenic
0.97
D
MetaSVM
Pathogenic
1.1
D
MutationAssessor
Uncertain
2.7
M
PhyloP100
6.0
PrimateAI
Uncertain
0.65
T
PROVEAN
Pathogenic
-5.3
D
REVEL
Pathogenic
0.90
Sift
Uncertain
0.0020
D
Sift4G
Uncertain
0.0020
D
Polyphen
1.0
D
Vest4
0.91
MVP
1.0
MPC
0.77
ClinPred
0.95
D
GERP RS
5.4
Varity_R
0.94
gMVP
0.98
Mutation Taster
=2/98
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.040
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs148789453; hg19: chr4-995590; API